CINCINNATI--(BUSINESS WIRE)--Sept. 20, 2007--Meridian Bioscience,
Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the Company
has been invited to present at the UBS Global Life Science Conference
at the Grand Hyatt New York in New York City. Bill Motto, Chairman and
CEO and Jack Kraeutler, President and COO, are scheduled to present on
Wednesday, September, 26, 2007 at 2:00 p.m. ET. A question and answer
session will follow and some of the information provided during the
session may not have been previously disclosed. Mr. Motto and Mr.
Kraeutler will be available to meet with investors during the
Conference.
Meridian invites investors to listen to management's remarks, live
over the Internet at 2:00 p.m. ET on September 26 on the Company's
website, www.meridianbioscience.com, under Events and Presentations on
the Investors Relations page. The archived broadcast will be available
at 5:00 p.m. ET on September 26, 2007 until October 27, 2007.
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these products and diagnostic tests provide accuracy,
simplicity and speed in the early diagnosis and treatment of common
medical conditions, such as gastrointestinal, viral and respiratory
infections. Meridian's diagnostic products are used outside of the
human body and require little or no special equipment. The Company's
products are designed to enhance patient well-being while reducing the
total outcome costs of healthcare. Meridian has strong market
positions in the areas of gastrointestinal and upper respiratory
infections, serology, parasitology and fungal disease diagnosis. In
addition, Meridian is a supplier of rare reagents, specialty
biologicals and related technologies used by biopharmaceutical
companies engaged in research for new drugs and vaccines. The Company
markets its products and technologies to hospitals, reference
laboratories, research centers, veterinary testing centers, physician
offices, diagnostics manufacturers and biotech companies in more than
60 countries around the world. The Company's shares are traded through
NASDAQ's Global Select Market, symbol VIVO. Meridian's website address
is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, President, 513-271-3700
SOURCE: Meridian Bioscience, Inc.
